
Oxaliplatin Injection
Product Details:
- Supply Ability : 50000 Piece Per Day
- Click to view more
Price And Quantity
- 5000 Piece
Trade Information
- Telegraphic Transfer (T/T), Days after Acceptance (DA), Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD), Cash Against Delivery (CAD)
- 50000 Piece Per Day
- 30-40 Days
- Yes
- Free samples are available
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
- All India
Product Description
We scaled to new heights of success in this domain, by manufacturing and exporting a highly effective range of Oxaliplatin Injection. The drug is highly effective for the treatment of colon cancer. To formulate the drug, our skilled manpower uses superior grade compounds, which we obtain from the authorized vendors. Available in both 50 and 100mg grades, our Oxaliplatin Injections 50mg and 100mg is highly demanded in the market.
Features :-
-
Highly effective
-
Accurately composite
-
Quality approved
Indications :-
- As adjuvant treatment of stage III colon cancer
- In combination with infusional 5-FU/LV, is indicated for the treatment of advanced carcinoma of the colon or rectum.
Dosage of Oxaliplatin Injections 50mg & 100mg :-
The recommended dose of oxaliplatin injection as single agent is 130/mg/m², given intravenously over at least 2 hours, every three-four weeks. In case of combination the recommended dose schedule given every two weeks is as follows :-
Day 1 : Oxaliplatin 85 mg/m² IV infusion in 250-500 ml of Dextrose 5% and Leucovorin 200 mg/m² IV infusion in Dextrose 5% both given over 120 minutes.
Day 2 : Leucovorin 200 mg/m² IV infusion over 120 minutes, followed by Fluorouracil 400 mg/m² IV bolus given over 2-4 minutes, followed by Fluorouracil 600 mg/m² IV infusion in 500 ml Dextrose 5% (recommended) as a 22-hour continuous infusion.
Renal Impairment : Required in severe impairment.
Other Products in 'Anticancer Medicine' category
![]() |
UNITED BIOTECH (P) LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Ltd. |